Patents by Inventor Anita Driessen-Levels

Anita Driessen-Levels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOTENSIN (1-7) ELUTING STENT
    Publication number: 20100055147
    Abstract: Medical devices with polymer coatings designed to control the release of bioactive agents in combination with angiotensin-(1-7) receptor agonists from medical devices are disclosed. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
    Type: Application
    Filed: October 26, 2007
    Publication date: March 4, 2010
    Inventors: Edze Jan Tijsma, Anita Driessen-Levels
  • Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function
    Patent number: 7176261
    Abstract: Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonists from medical devices are disclosed. The present application also discloses providing vascular stents with angiotensin-(1-7) receptor agonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: February 13, 2007
    Assignee: Medtronic, Inc.
    Inventors: Edze Jan Tijsma, Anita Driessen-Levels, Marc Hendriks
  • Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function
    Publication number: 20060088572
    Abstract: Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonists from medical devices are disclosed. The present application also discloses providing vascular stents with angiotensin-(1-7) receptor agonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
    Type: Application
    Filed: October 21, 2005
    Publication date: April 27, 2006
    Applicant: Medtronic, Inc.
    Inventors: Edze Tijsma, Anita Driessen-Levels, Marc Hendriks